Keyphrases
Bortezomib
100%
Functional Characterization
100%
Flow Cytometry
100%
Myeloma Cells
100%
Phenotypic Characterization
100%
Mass Cytometry
100%
Multiple Myeloma
40%
Drug Resistance
20%
Time-of-flight Mass Spectrometry
20%
Epitope
20%
CD56
20%
Protease Inhibitors
20%
Multiple Treatments
20%
Adhesion Molecules
20%
Resistant Cells
20%
Treatment Failure
20%
3C 66A
20%
Plasma Cell Neoplasm
20%
Immunophenotypic Characterization
20%
Heavy Metal Ions
20%
Bortezomib Resistance
20%
U266
20%
Clinical Outcomes
20%
Immunophenotypic Profile
20%
Malignant Plasma Cells
20%
Immunology and Microbiology
Mass Cytometry
100%
Multiple Myeloma Cell Line
100%
Multiple Myeloma
100%
Drug Resistance
33%
Time-of-Flight Mass Spectrometry
33%
Epitope
33%
Myeloma Cell
33%
Immunoglobulin Producing Cell
33%
Cell Adhesion Proteins
33%
Proteasome
33%
Immunology
33%